| アブストラクト | The US Vaccine Adverse Event Reporting System contains case reports of autoimmune diseases (ADs) occurring following vaccinations. ADs are rare and occur in unvaccinated people, making the potential association between vaccines and ADs challenging to evaluate. Developing mechanistic pathways that link genes, immune mediators, vaccine components and ADs would be helpful for hypothesis generation, enhancing theories of biologic plausibility and grouping rare autoimmune adverse events to increase the ability to detect and evaluate safety signals. Here, we propose a conceptual framework for investigating the genetics of ADs as safety signals following vaccination, potentially contributing to the identification of relevant biomarkers. We also discuss a study design that incorporates genetic information into postmarket clinical evaluation of autoimmune adverse events following vaccination. |
|---|
| 組織名 | Office of Biostatistics & Epidemiology, Center for Biologics Evaluation &;Research, US Food & Drug Administration, 10903 New Hampshire Avenue, Silver;Spring, MD 20993-0002, USA.;Johns Hopkins University, School of Public Health, Baltimore MD, USA.;Division of Biostatistics, Office of Biostatistics & Epidemiology, Center for;Biologics Evaluation & Research, US Food & Drug Administration, 10903 New;Hampshire Avenue, Silver Spring, MD 20993-0002, USA. |
|---|
